Evaluation of Medication Management Service
About this study
Medication management services (MMS) is a pharmacist-led service of optimizing the medication use and health outcomes, by promoting medication safety and enhancing the ability in self-management of health and diseases of patients and their caregivers. Yet, only limited evidence on the implementation of MMS service in Hong Kong is available. The goal of this clinical trial is to evaluate the cost effectiveness and effects of implementing MMS in community pharmacies owned by 8 non-government organizations (NGOs) in Hong Kong on humanistic and clinical outcomes in patients with hypertension and/or type II diabetes mellitus. The clinical trial aims to look into the following aspects: * To evaluate the perception and satisfaction of patients on MMS service * To investigate whether MMS could improve patients' adherence to their medication regimen, health-related quality of life, health outcomes and health service utilization, as well as their ability to understand and cope with their illness and drug-related problems * To identify and categorize the types of drug-related problems identified during MMS * To evaluate the cost-effectiveness of implementing MMS in community pharmacies MMS services will be rolled out in a total of 8 NGO community pharmacies progressively (2 pharmacies per phase) in 4 successive phases. Participants will complete the questionnaires at the following time points throughout the trial, namely 1) during recruitment, 2) baseline (1 month before MMS), 3) 3 months after MMS begins, 4) 12 months after MMS begins, and 5) 24 months after MMS begins. Researchers will compare the results of questionnaires conducted at different time points to identify the potential changes in the effects of MMS. Furthermore, researchers will link up the electronic health records of the participants and identify the potential changes in the health outcomes and health service utilizations after receiving MMS.
- Condition
- Medication Adherence, Medication Safety, Diabetes Mellitus, Type 2, Hypertension, Polypharmacy, High Risk Medications
- Tested
- Medication Management Service (MMS)
- Sponsor
- The University of Hong Kong
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 10
- Minimum age: 18 years
- Study condition: Medication Adherence, Medication Safety, Diabetes Mellitus, Type 2, Hypertension, Polypharmacy, High Risk Medications
- aged 18 years or above
- diagnosed with Type 2 diabetes mellitus and/or hypertension
- having regular follow-up on Type 2 diabetes mellitus and/or hypertension at Hospital Authority
- no A\&E admission/hospitalization in the past 3 months
- no recent changes in medication regimen in the past 3 months
- polypharmacy (taking 5 or more chronic medications)
- using at least 1 high-risk medication (Anticoagulants, Oral hypoglycaemics, Insulins, psychotropic medications or immunosuppressants)
- able to communicate in Cantonese and/or English
Exclusion 3
- aged below 18
- unable to give informed consent
- unable to communicate in Cantonese and/or English
Where
8 sites, 8 recruiting
Aberdeen Kai-Fong Welfare Association A-Lively Community Pharmacy
Hong Kong, Hong Kong
Health In Action Community Pharmacy
Hong Kong, Hong Kong
Hong Kong Sheng Kung Hui Welfare Council Community Pharmacy
Hong Kong, Hong Kong
PHARM+ Haven of Hope Community Pharmacy
Hong Kong, Hong Kong
PHARM+ Pok Oi Hospital Community Pharmacy
Hong Kong, Hong Kong
PHARM+ St. James' Settlement Community Pharmacy
Hong Kong, Hong Kong
and 2 more sites on ClinicalTrials.gov
Contact
-
Ian Chi Kei Wong, PhD
+852 3917 9441 wongick@hku.hk
-
Eric Yuk Fai Wan, PhD
+852 2831 5057 yfwan@hku.hk
Potential match only. Final eligibility is determined by the study team.